Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04180930 · ClinicalTrials.gov registry record
An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
A clinical trial of Stress Disorders, Post-Traumatic, sponsored by U.S. Army Medical Research and Development Command.
- Recruiting
- Registry status
- 950
- Enrollment target
- 3
- Study locations
NCT04180930 is a study of Stress Disorders, Post-Traumatic that is actively recruiting participants, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 950 participants, above the 141-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (574% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT04180930, a study of Stress Disorders, Post-Traumatic, is actively recruiting participants, sponsored by U.S. Army Medical Research and Development Command.
- RECRUITING
- Registry status
- 950 participants
- Enrollment target
- 3
- Study locations
Study Summary
Given the high prevalence of post-traumatic stress disorder (PTSD) in veterans and active duty military, the focus of this research study is to test the reliability of two new PTSD assessments, the Clinician Administered PTSD Scale for DSM-5 (CAPS-5) and the PTSD Symptom Scale Interview for DSM-5 (PSSI-5) and compare the results between the two new assessments and the previous "gold standard", the Clinician Administered PTSD Scale for DSM-IV (CAPS-IV). Biomarkers believed to be related to PTSD (e.g., biofluid biomarkers, cognitive and physiological markers, and neural activity as measured by EEG) will be collected to inform targeted interventions in specific groups of patients and other large-scale biomarker discovery efforts in the field. Participants will be 950 male and female active duty military and veterans ages 18 or older who have been exposed to at least one traumatic event.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST CAPS-5
- DIAGNOSTIC_TEST PSSI-5
- DIAGNOSTIC_TEST CAPS-IV
Study Locations (3)
Hawaii
- Tripler Army Medical Center - Honolulu
Kentucky
- Cincinnati VA Medical Center - Trauma Recovery Center - Fort Thomas
Maryland
- Walter Reed National Military Medical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 950 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04180930
The ClinicalTrials.gov registry entry for NCT04180930 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 950 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 141-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (574% higher). The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 3 interventions - of which CAPS-5 is the first listed.
NCT04180930 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Hawaii, Kentucky, Maryland.
Frequently Asked Questions
What is clinical trial NCT04180930 about?
NCT04180930 is a clinical study titled "An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample". Given the high prevalence of post-traumatic stress disorder (PTSD) in veterans and active duty military, the focus of this research study is to test the reliability of two new PTSD assessments, the Clinician Administered PTSD Scale for DSM-5 (CAPS-5) and the PTSD Symptom Scale Interview for DSM-5 (P...
What is the current status of trial NCT04180930?
This trial is currently recruiting. The enrollment target is 950 participants. The study started on 2019-04-15. Estimated completion is 2025-06-30.
What conditions does trial NCT04180930 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT04180930?
The interventions under investigation include: CAPS-5 (DIAGNOSTIC_TEST), PSSI-5 (DIAGNOSTIC_TEST), CAPS-IV (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04180930?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04180930 being conducted?
This trial has 3 study locations across Hawaii, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Overcontrol and Suicide in PTSD
RECRUITING
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
MDMA for Co-occurring PTSD and OUD After Childbirth
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.